[Study on patient satisfaction with the treatment of mycosis on the extremities with terbinafine (SETTA)].
BACKGROUND
The SETTA study is an open-label, multicenter, prospective, observational study carried out in order to evaluate satisfaction with the treatment of mycosis on the extremities with terbinafine.


METHODS
Patients clinically diagnosed with tinea pedis or tinea unguium after a single visit were recruited. Follow up was through a questionnaire that the patient was to send back. The two groups were statistically compared by means of three analyses: descriptive, effectiveness and safety.


RESULTS
In the effectiveness analysis, significant differences were observed in the evolution of the tinea, the overall score and degree of adherence to the treatment, with these being more positive in the group with tinea pedis. In the safety analysis, adverse events, none of them serious, were reported in 24 patients.


CONCLUSIONS
This study reflects a high degree of satisfaction and safety in the use of terbinafine to treat patients with mycosis on the extremities.
Servicio de Dermatología, Hospital Universitario de Bellvitge, Barcelona, Spain. 34886jss@comb.es
Julia M
JM
Sánchez-Schmidt
Sonia
S
Giménez-Jovani
Jordi
J
Peyrí-Rey
D000935:Antifungal Agents / Q000627:therapeutic use*; D006801:Humans; D009281:Naphthalenes / Q000627:therapeutic use*; D014009:Onychomycosis / Q000188:drug therapy*; D017060:Patient Satisfaction; D011446:Prospective Studies; D000077291:Terbinafine; D014008:Tinea Pedis / Q000188:drug therapy*
D000935:Antifungal Agents; D009281:Naphthalenes; D000077291:Terbinafine